🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of Part 1 of this study is to evaluate the safety and tolerabil...
Status
Terminated
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2012-12
Trial ID
NCT01727336
Treatments Being Tested
Assess whether therapy with axitinib, a potent angiogenic inhibitor of the ...
Status
Completed
Location
Marburg Universitätsklinikum Giessen und Marburg GmbH
Start Date
2011-11
Trial ID
NCT01744249
Treatments Being Tested
This is a study of Axitinib versus placebo as monotherapy for people with c...
Status
Completed
Location
Imperial College Healthcare NHS Trust
Start Date
2012-09-17
Trial ID
NCT04355156
The purpose of this study is to determine whether investigational study dru...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-07
Trial ID
NCT00471146
Treatments Being Tested
Trial to Evaluate the Safety and Efficacy of SCAI-005 Ophthalmic solution i...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-01
Trial ID
NCT07607561
Treatments Being Tested
This phase III trial compares the effect of adding live biotherapy, MO-03, ...
Status
Recruiting
Location
Highlands Oncology Group - Fayetteville
Start Date
2026-06-05
Trial ID
NCT07383441
To assess the single-dose and multiple-dose pharmacokinetics (PK), safety a...
Status
Completed
Location
The Catholic University, Seoul ST. Mary's Hospital
Start Date
2025-05-29
Trial ID
NCT06969001
Treatments Being Tested
The study is designed to demonstrate that axitinib plus best supportive car...
Status
Completed
Location
Alta Bates Summit Comprehensive Cancer Center
Start Date
2010-12-06
Trial ID
NCT01210495
Treatments Being Tested
This randomized phase II trial studies how well axitinib with or without an...
Status
Active Not Recruiting
Location
Los Angeles County-USC Medical Center
Start Date
2017-07-19
Trial ID
NCT03092856
Treatments Being Tested